Mika Reiner Mayer is a patent counseling and prosecution partner. Widely known for her strategic insights and deep understanding of business, she is the go-to diligence counsel in Silicon Valley for life science companies and their investors. Mika is one of the most sought-after lawyers in patent prosecution and strategic portfolio management for life sciences startups and established companies alike. Mika has extensive experience with investor-side and company-side patent due diligence. She has led hundreds of patent due diligence reviews, ranging in size from small seed investments to multibillion dollar acquisitions in the medical device, drug delivery and pharmaceutical fields. On the company-side, her clients include Gilead Sciences, W.L. Gore & Associates, Alcon, Magic Leap and Astellas Pharma. On the investor-side, she has represented clients such as Vivo Ventures, Kleiner Perkins Caufield & Byers, GE Ventures, Vertex Healthcare Ventures and Canaan Partners. Clients rely on her ability to translate IP risks into business risks with ease, and to provide strategic guidance. As Intellectual Asset Management's Guide to the Leading Patent Professionals notes, "Mika Mayer is a touchstone IP due diligence lawyer for life sciences companies and their investors."
